Cochlear (OTCMKTS:CHEOF – Get Free Report) is expected to be issuing its results before the market opens on Tuesday, August 18th. Analysts expect the company to announce earnings of $1.17 per share and revenue of $804.0270 million for the quarter.
Cochlear Price Performance
Shares of OTCMKTS:CHEOF opened at $93.00 on Monday. Cochlear has a 12-month low of $64.39 and a 12-month high of $207.71. The business has a 50-day moving average price of $81.62 and a 200 day moving average price of $107.39.
Cochlear Company Profile
Cochlear (OTCMKTS:CHEOF) is a global medical device company specializing in implantable hearing solutions. The company researches, develops, manufactures and markets cochlear implants, bone conduction hearing devices and acoustic implants designed to improve hearing outcomes for individuals with varying degrees of hearing loss. Cochlear’s product portfolio includes implant processors, electrode arrays and sound processor accessories, supported by proprietary digital signal processing technologies.
Founded in 1981 and headquartered in Sydney, Australia, Cochlear has grown into a multi-national organization with operations in North America, Europe, Asia Pacific and Latin America.
Read More
- Five stocks we like better than Cochlear
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
